Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Recruiting 2

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Colorectal Neoplasms 18Colonic Neoplasms 7Rectal Neoplasms 5Neoplasm Metastasis 5Neoplasms 4Carcinoma, Non-Small-Cell Lung 4Pancreatic Neoplasms 3Unresectable Metastatic Colorectal Cancer 2Ovarian Neoplasms 2Gastrointestinal Neoplasms 2Breast Neoplasms 2Stomach Neoplasms 1Solid Tumors 1Prostatic Neoplasms 1Melanoma 1Lung Neoplasms 1Locally-advanced Rectal Cancer 1Gastroesophageal Adenocarcinoma 1Endometrial Neoplasms 1Colorectal Cancer Metastatic 1Cholangiocarcinoma 1Central Nervous System Neoplasms 1Carcinoma, Renal Cell 1Carcinoma, Hepatocellular 1Advanced Solid Tumors 1Advanced Solid Tumor 1

Interventions

Folfox protocol 2pembrolizumab 1IFL protocol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1 × Unresectable Metastatic Colorectal Cancer × Folfox protocol × Clear all
NCT04991948 2022-03-09

Study of Pembrolizumab Treatment After CYAD-101 With FOLFOX Preconditioning in Metastatic Colorectal Cancer

Celyad Oncology SA

Phase 1 Recruiting
34 enrolled
Gastrointestinal

Unresectable Metastatic Colorectal Cancer

NCT03692429 2020-11-20

alloSHRINK

Celyad Oncology SA

Phase 1 Recruiting
49 enrolled
Gastrointestinal

Unresectable Metastatic Colorectal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡